| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.074 | 0.1 |